Lixte Biotechnology
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -1,009 | -966 | -1,025 | -1,024 |
EBIT | -1,933 | -2,051 | -2,048 | |
Net Income | -1,010 | -971 | -1,032 | -1,018 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -819 | -789 | -902 | -944 |
Cash | 2,595 | 3,414 | 4,203 | 5,105 |
Basic Shares | 2,249 | 2,249 | 2,249 | 2,074 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -5,090 | -6,300 | -6,719 | -3,261 |
EBIT | -10,180 | -12,611 | -13,440 | -6,527 |
Net Income | -5,087 | -6,304 | -6,735 | -3,263 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -4,293 | -4,611 | -4,142 | -2,131 |
Cash | 4,203 | 5,353 | 4,823 | 5,069 |
Basic Shares | 1,915 | 158 | 1,347 | 1,127 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$0.44 |
2024-03-31 | -$0.43 |
2023-12-31 | -$0.45 |
2023-09-30 | -$0.49 |
